Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Erythrocyte membrane proteins are a large and functionally diverse group of proteins embedded in or associated with the red blood cell plasma membrane[2][5][1]. They include transmembrane transporters (such as band 3/anion exchanger 1 and Rh proteins), gas and ion channels (e.g., PIEZO1, aquaporin 1), adhesion molecules, structural proteins (spectrin, ankyrin, protein 4.1R), and receptors responsible for blood group antigenicity (glycophorins, Duffy antigen, Kell, etc.)[2][5][1][3]. Collectively, they ensure membrane integrity, deformability, gas exchange, immune recognition, and homeostasis. Mutations or deficiencies in specific erythrocyte membrane proteins result in clinically significant hemolytic and membrane disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Erythrocyte membrane proteins.